Abstract:Curcumin, a naturally occurring antioxidant, has various beneficial effects in the treatment of human diseases. However, little information regarding the protection it provides against acute liver injury is available. The present study investigated the protective effects of curcumin against D-galactosamine (D-GalN)/lipopolysaccharide (LPS)-induced acute liver injury in mice. A total of 40 male Kunming mice were randomly assigned to 5 groups: 1) mice administered saline vehicle injection (control), 2) mice administered 200 mg/kg body weight (BW) curcumin by i.p. injection (CUR), 3) mice administered D-GalN/LPS (700 mg and 5 μg/kg BW) via i.p. injection (GL), 4) mice administered 200 mg/kg BW curcumin i.p. 1 h before D-GalN/LPS injection (CUR-GL), and 5) mice administered 200 mg/kg BW curcumin i.p. 1 h after D-GalN/LPS injection (GL-CUR). Twenty h after D-GalN/LPS injection, serum alanine aminotransferase activities were 18.5% and 13.5% lower (P < 0.05) and aspartate aminotransferase (AST) activities were 26.6% and 9.6% lower (P < 0.05) in the CUR-GL and GL-CUR groups, respectively, than in the GL group. The CUR-GL and GL-CUR groups had 64.4% and 15.0% higher (P < 0.05) mitochondrial membrane potentials, respectively, and the CUR-GL group had a 44.7% lower reactive oxygen species concentration than the GL group (P < 0.05). Mitochondrial manganese superoxide dismutase activities were 111% and 77.9% higher (P < 0.05) and the percentages of necrotic cells were 47.0% and 32.4% lower (P < 0.05) in the CUR-GL and GL-CUR groups, respectively, than in the GL group. Liver mRNA levels of sirtuin 1 (Sirt1) were 56.4% lower (P < 0.05) in the CUR-GL group than in the GL group. Moreover, compared with the GL-CUR group, the CUR-GL group had an 18.7% lower serum AST activity, a 31.7% lower mitochondrial malondialdehyde concentration, a 36.0% lower hepatic reactive oxygen species concentration, and a 43.0% higher mitochondrial membrane potential. These results suggested that curcumin protects against D-GalN/LPS–induced liver damage by the enhancing antioxidant defense system, attenuating mitochondrial dysfunction and inhibiting apoptosis. This was especially true for curcumin pretreatment, which highlighted its promise as a preventive treatment for acute liver injury in clinical settings.

Curcumin Protects Against Liver Fibrosis by Attenuating Infiltration of Gr1hi Monocytes Through Inhibition of Monocyte Chemoattractant Protein-1.

Curcumin Reduces Ly6Chi Monocyte Infiltration to Protect Against Liver Fibrosis by Inhibiting Kupffer Cells Activation to Reduce Chemokines Secretion.

Protective Effects of Curcumin Against Hepatic Fibrosis Induced by Carbon Tetrachloride: Modulation of High-Mobility Group Box 1, Toll-Like Receptor 4 and 2 Expression

Inhibition by Curcumin of Multiple Sites of the Transforming Growth Factor-Beta1 Signalling Pathway Ameliorates the Progression of Liver Fibrosis Induced by Carbon Tetrachloride in Rats

Protective Effects of Curcumin Against Liver Fibrosis Through Modulating DNA Methylation

Curcumin Protects Against CCl4-induced Liver Fibrosis in Rats by Inhibiting HIF-1α Through an ERK-dependent Pathway.

Curcumin Attenuates on Carbon Tetrachloride-Induced Acute Liver Injury in Mice via Modulation of the Nrf2/HO-1 and TGF-β1/Smad3 Pathway

Curcumin Ameliorates Intrahepatic Angiogenesis and Capillarization of the Sinusoids in Carbon Tetrachloride-Induced Rat Liver Fibrosis

The Potential Mechanism of the Anti-Liver Fibrotic Effect of Curcumin in the Gut-Liver Axis

Effects of curcumin on expression of collagen Ⅰ in fibrotic liver induced by carbon tetrachoride in rats

Curcumin Attenuates D-Galactosamine/Lipopolysaccharide–Induced Liver Injury and Mitochondrial Dysfunction in Mice

Curcumin Protects Against Concanavalin A-Induced Hepatitis in Mice Through Inhibiting the Cytoplasmic Translocation and Expression of High Mobility Group Box 1

Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation

Prophylactic Effects of Curcumin on Rats Hepatic Fibrosis

Effect of Curcumin on Rat Hepatic Fibrosis Induced by Carbon Tetrachoride

A role for curcumin in preventing liver fibrosis in animals: a systematic review and meta-analysis

Curcumin protects against hepatic stellate cells activation and migration by inhibiting the CXCL12/CXCR4 biological axis in liver fibrosis：A study in vitro and in vivo

Suppression Of The Tgf-Beta/Smad Signaling Pathway And Inhibition Of Hepatic Stellate Cell Proliferation Play A Role In The Hepatoprotective Effects Of Curcumin Against Alcohol-Induced Hepatic Fibrosis

Curcumin Attenuated Acute Propionibacterium Acnes-Induced Liver Injury Through Inhibition of HMGB1 Expression in Mice.

Protective effects of curcumin against chronic alcohol-induced liver injury in mice through modulating mitochondrial dysfunction and inhibiting endoplasmic reticulum stress

Emodin Alleviates Liver Fibrosis of Mice by Reducing Infiltration of Gr1(hi) Monocytes